Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Operating Margin: 2020-2025

Historic Operating Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 15.07%.

  • Cellebrite DI's Operating Margin fell 313.00% to 15.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.47%, marking a year-over-year decrease of 112.00%. This contributed to the annual value of 14.18% for FY2024, which is 396.00% up from last year.
  • Latest data reveals that Cellebrite DI reported Operating Margin of 15.07% as of Q3 2025, which was up 18.39% from 12.73% recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Operating Margin peaked at 18.20% during Q3 2024, and registered a low of 0.19% during Q1 2023.
  • Its 3-year average for Operating Margin is 12.14%, with a median of 13.05% in 2024.
  • As far as peak fluctuations go, Cellebrite DI's Operating Margin plummeted by 1,218bps in 2021, and later skyrocketed by 1,450bps in 2023.
  • Quarterly analysis of 5 years shows Cellebrite DI's Operating Margin stood at 6.34% in 2021, then surged by 673bps to 13.07% in 2022, then surged by 306bps to 16.13% in 2023, then tumbled by 170bps to 14.42% in 2024, then tumbled by 313bps to 15.07% in 2025.
  • Its Operating Margin was 15.07% in Q3 2025, compared to 12.73% in Q2 2025 and 11.41% in Q1 2025.